Biotech M&A is heating up, and Mirum Pharmaceuticals stands out. Discover why analysts predict a 50% upside and long-term ...

Stocks are adjusting to yield curve normalization, not inflation fears. Job openings and ISM Services PMI rise suggest ...

Sana Biotechnology, Inc. shares surge as a breakthrough in diabetes therapy sparks investor interest. Click for my updated ...

Fagron (ARSUF) has refocused its M&A strategy, regaining market trust despite recent FDA issues. Read why I think the stock ...

The key pillar of my bull thesis is the company's ability to complete the $1.66 billion loan from the Department of Energy.

BUI gets positive ratings, DNP CEFs faces strong sell signals. Find out how a 12% distribution hike affects their current ...

Palantir Technologies Inc. stock is in a technical bear market, down 20% from its all-time high. Explore more details here.

GSK (GSK) stock is in focus as the company is nearing a $1B deal to acquire IDRx, a private biotech focused on a rare ...

US corporate bankruptcy filings hit a 14-year high in 2024 as filings continued at a steady clip in December 2024 and ...

The U.S. Treasury 10-year yield could trend toward 5% in 2025, supported by a combination of historical averages and a ...

US small-cap equities are at a critical juncture. Valuation gap between small and large-cap stocks grown exponentially wide ...

Luminar Technologies has strong growth potential with partnerships like Volvo and Nvidia, but faces financial challenges and ...